1) Brachen MB, Shepard MJ, Collins WF, et al:Efficacy of methylprednisolon in acute spinal cord injury study. JAMA 251:4552, 1984
2) Brachen MB, Shepard MJ, Collins WF, et al:A randomized, controlled trial of methylpredonisolone or naloxone in the treatment of acute spinal-cord injury. Results of the second National Acute Spinal Cord Injury Study. N Engl J Med 322:1405-1411, 1990
3) Brachen MB, Shepard MJ, Collins WF, et al:Methylpredonisolone or naloxone in the treatment of acute spinal-cord injury:1-year follow up data. Results of the second National Acute Spinal Cord Injury Study. J Neurosurg 76:23-31, 1992
4) Brachen MB, Shepard MJ, Holford TR, et al:Administration of Methylpredonisolone for 24 or 48 hours or Tirilazad Mesylate for 48 hours in the treatment of acute spinal cord. JAMA 277:1597-1604, 1997
5) Donald RG, Susan B, Sepic MS, et al:Roenytgenographic findings of the cervical spine in asymptomatic people. Spine 11:521-524, 1986
6) 藤原桂樹,河野譲二:非骨傷性頚髄損傷.NEW MOOK整形外科No.4,pp169-180,金原出版,1998
7) 水野順一,中川 洋,井上辰志・他:骨傷のない頚髄損傷.手術療法の立場から.脊椎脊髄16:375-380,2003
8) 松永俊二,林 協司,小宮節郎:骨傷のない頚髄損傷:保存療法の立場から.脊椎脊髄16:381-384,2003
9) 大谷 清,安部 弘,角家 暁・他:急性期脊髄損傷に対するコハク酸メチルプレドニゾロンナトリウムの臨床成績.脊椎脊髄7:467-472,2006
10) Pointilart V, Petitjean ME, Wiart JM, et al:Parmacological therapy of spinal cord injury during the acute phase. Spinal Cord 38:71-76, 2000
11) 新宮彦助:疫学調査から見た高齢者脊髄損傷.日本パラプレジア医学会誌8:28-29,1995
12) 植田尊善,河野 修:非骨傷性頚損に対する急性期除圧術の効果.臨整外41:467-472,2006